Radius Health Inc (RDUS) - Financial and Strategic SWOT Analysis Review

August 2021 | 55 pages | ID: R3043B71CACEN
GlobalData

Abstracts

Radius Health Inc (RDUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Radius Health Inc (Radius Health), formerly NuVios Inc, is a biopharmaceutical company that develops and markets novel medicines for bone health, and endocrine diseases. The company’s marketed product includes abaloparatide injection, which is indicated for the treatment of postmenopausal women with osteoporosis. Its pipeline encompasses abaloparatide subcutaneous injection (SC) for high risk of fracture in men with osteoporosis; abaloparatide transdermal (TD) patch for postmenopausal women with osteoporosis; elacestrant (RAD1901) for estrogen-receptor (ER)-positive breast cancer; and RAD140 as an oral treatment for triple-negative, ER-positive, and ER-negative breast cancers. The company operates in Parsippany, Wayne and Cambridge in the US. Radius Health is headquartered in Boston, Massachusetts, the US.

Radius Health Inc Key Recent Developments

Aug 05,2021: Radius Health Announces Second Quarter and Year-to-Date Results
Aug 05,2021: Radius Health Second Quarter and Year-to-Date Results
Jul 27,2021: Radius Health business update
Jul 20,2021: Radius Health to Announce Second Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, August 5, 2021
Jun 02,2021: Radius Health business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Radius Health Inc - Key Facts
Radius Health Inc - Key Employees
Radius Health Inc - Key Employee Biographies
Radius Health Inc - Major Products and Services
Radius Health Inc - History
Radius Health Inc - Company Statement
Radius Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Radius Health Inc - Business Description
Business Segment: License Revenue
Performance
Business Segment: Product Revenue
Performance
R&D Overview
Radius Health Inc - Corporate Strategy
Radius Health Inc - SWOT Analysis
SWOT Analysis - Overview
Radius Health Inc - Strengths
Radius Health Inc - Weaknesses
Radius Health Inc - Opportunities
Radius Health Inc - Threats
Radius Health Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Radius Health Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 05, 2021: Radius Health Announces Second Quarter and Year-to-Date Results
Aug 05, 2021: Radius Health Second Quarter and Year-to-Date Results
Jul 27, 2021: Radius Health business update
Jul 20, 2021: Radius Health to Announce Second Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, August 5, 2021
Jun 02, 2021: Radius Health business update
May 07, 2021: Radius Health First Quarter 2021 Results
Apr 22, 2021: Radius Health business update
Feb 25, 2021: Radius Health: Fourth quarter and full year results
Feb 17, 2021: Radius Health to Present at 10th Annual SVB Leerink Global Healthcare Conference
Feb 16, 2021: Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Radius Health Inc, Key Facts
Radius Health Inc, Key Employees
Radius Health Inc, Key Employee Biographies
Radius Health Inc, Major Products and Services
Radius Health Inc, History
Radius Health Inc, Other Locations
Radius Health Inc, Subsidiaries
Radius Health Inc, Key Competitors
Radius Health Inc, Ratios based on current share price
Radius Health Inc, Annual Ratios
Radius Health Inc, Annual Ratios (Cont...1)
Radius Health Inc, Interim Ratios
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Radius Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Radius Health Inc, Performance Chart (2016 - 2020)
Radius Health Inc, Ratio Charts
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Radius Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021